These experimental findings confirm that substituted methoxy (-OCH3) and bromophenols may be used as leads for generating potent CAI and AChE inhibitors associated with some global disorders, including AD, epilepsy, and glaucoma. This evidence concerns the gene ACHE and epilepsy.